Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (341-350 of 606) with videos related to

Pageof 61
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2016
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry DataMarc A Riedl, Anette Bygum, William Lumry, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|February 26, 2026
A Randomized Dose-Finding Study of Anti-KIT Barzolvolimab in Patients with Chronic Spontaneous UrticariaMartin Metz, Essack Mitha, Jeffrey Leflein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Allergy|July 21, 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE StudyAleena Banerji, Jonathan A Bernstein, Douglas T Johnston, et al.
American Journal of Human Genetics|June 4, 2024
Impact of genome build on RNA-seq interpretation and diagnosticsRachel A Ungar, Pagé C Goddard, Tanner D Jensen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2025
Validation of the Visual Analog Scale in Perennial Allergic and Non-Allergic Rhinitis: Association with Symptom Severity and Quality of LifeChamard Wongsa, Pakpoom Wongyikul, Piyaporn Chokevittaya, et al.
The Patient|January 28, 2025
Assessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment ProfilesAna Maria Giménez-Arnau, Maria-Magdalena Balp, Andrii Danyliv, et al.
Allergy and Asthma Proceedings|May 16, 2015
Current state of hereditary angioedema management: a patient surveyAleena Banerji, Paula Busse, Sandra C Christiansen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Pageof 61

Showing results (341-350 of 606) with videos related to

Sort By:
Pageof 61
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2016
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry DataMarc A Riedl, Anette Bygum, William Lumry, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|February 26, 2026
A Randomized Dose-Finding Study of Anti-KIT Barzolvolimab in Patients with Chronic Spontaneous UrticariaMartin Metz, Essack Mitha, Jeffrey Leflein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Allergy|July 21, 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE StudyAleena Banerji, Jonathan A Bernstein, Douglas T Johnston, et al.
American Journal of Human Genetics|June 4, 2024
Impact of genome build on RNA-seq interpretation and diagnosticsRachel A Ungar, Pagé C Goddard, Tanner D Jensen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2025
Validation of the Visual Analog Scale in Perennial Allergic and Non-Allergic Rhinitis: Association with Symptom Severity and Quality of LifeChamard Wongsa, Pakpoom Wongyikul, Piyaporn Chokevittaya, et al.
The Patient|January 28, 2025
Assessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment ProfilesAna Maria Giménez-Arnau, Maria-Magdalena Balp, Andrii Danyliv, et al.
Allergy and Asthma Proceedings|May 16, 2015
Current state of hereditary angioedema management: a patient surveyAleena Banerji, Paula Busse, Sandra C Christiansen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Pageof 61